Log In
BCIQ
Print this Print this
 

Tubulin

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Tubulin

BCIQ
Print ChartPrint this
1 0 0 0 0 0 0 0 0 1 0 1 0 2 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 6 7 0 17 9 17 1 5 2 9 1 1 0 0 0 0 0 0 0
Phases of DevelopmentPreclinicalINDPhase IPhase I/IIPhase IIPhase II/IIIPhase IIIApprovedMarketed
Autoimmune

1

1

0

0

0

0

0

0

0

Cancer

7

0

17

9

17

1

5

2

9

Cardiovascular

0

0

0

0

0

0

0

0

6

Endocrine / Metabolic

0

0

0

0

0

0

0

0

1

Neurology

1

0

1

0

2

0

1

0

0

Ophthalmic

1

0

0

0

0

0

0

0

0




 Products Targeting Tubulin
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

17

$4,238.5M

$1,943.2M

$195.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today